Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKRP) Change in Receivables (2016 - 2024)

Bruker's Change in Receivables history spans 15 years, with the latest figure at $51.3 million for Q4 2024.

  • For Q4 2024, Change in Receivables rose 546.09% year-over-year to $51.3 million; the TTM value through Dec 2024 reached $40.6 million, up 4411.11%, while the annual FY2025 figure was -$54.2 million, 233.5% down from the prior year.
  • Change in Receivables reached $51.3 million in Q4 2024 per BRKRP's latest filing, up from $18.8 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $51.3 million in Q4 2024 to a low of -$29.5 million in Q1 2020.
  • Average Change in Receivables over 5 years is $8.2 million, with a median of $600000.0 recorded in 2021.
  • Peak YoY movement for Change in Receivables: skyrocketed 1607.69% in 2021, then plummeted 1210.0% in 2023.
  • A 5-year view of Change in Receivables shows it stood at -$3.9 million in 2020, then skyrocketed by 1320.51% to $47.6 million in 2021, then plummeted by 40.76% to $28.2 million in 2022, then crashed by 140.78% to -$11.5 million in 2023, then surged by 546.09% to $51.3 million in 2024.
  • Per Business Quant, the three most recent readings for BRKRP's Change in Receivables are $51.3 million (Q4 2024), $18.8 million (Q3 2024), and -$13.9 million (Q2 2024).